M13-367 (R/R)

M13-367 (R/R)

A Phase I/II Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma (MM)


Study treatments

Venetoclax (oral) in combination with dexamethasone


Inclusion criteria


Exclusion criteria


Participating sites

Link